Medis has four nominations for the upcoming 2015 Global Generics & Biosimilar Awards. The awards are set up to recognize the absolute best in the global generics and biosimilar industries and take place alongside the CPhI Worldwide in Madid. A panel of expert judges weighed over 100 entries this year, covering a wide variety of disciplines in the generics and biosimilar industries.
The nominations for Medis came in the categories of Business Development of the Year, Company of the Year EMEA and outright Company of the Year. Valur Ragnarsson, Medis CEO, is also nominated as Leader of the Year. We are truly proud of our global team of employees who have worked hard as ever this past year, delivering strong results in partnership with our customers around the world. The nominations stand as a testament to their hard work and resilience.
Last year, Medis was a joint runner-up for the Business Development of the Year award and this year we are thankful to be up for an award in four different categories. Winners of the 13 different categories of the 2015 Global Generics & Biosimilar awards will receive their awards during a cocktail reception on 13 October at the Palacio Municipal de Congresos Feria de Madrid. The awards ceremony will be co-hosted by Generics-bulletin and Ark Patent Intelligence.